HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term follow-up after endovascular treatment of acute aortic emergencies.

AbstractPURPOSE:
To investigate the long-term outcome and efficacy of emergency treatment of acute aortic diseases with endovascular stent-grafts.
METHODS:
From September 1995 to April 2007, 37 patients (21 men, 16 women; age 53.9 +/- 19.2 years, range 18-85 years) with acute complications of diseases of the descending thoracic aorta were treated by endovascular stent-grafts: traumatic aortic ruptures (n = 9), aortobronchial fistulas due to penetrating ulcer or hematothorax (n = 6), acute type B dissections with aortic wall hematoma, penetration, or ischemia (n = 13), and symptomatic aneurysm of the thoracic aorta (n = 9) with pain, penetration, or rupture. Diagnosis was confirmed by contrast-enhanced CT. Multiplanar reformations were used for measurement of the landing zones of the stent-grafts. Stent-grafts were inserted via femoral or iliac cut-down. Two procedures required aortofemoral bypass grafting prior to stent-grafting due to extensive arteriosclerotic stenosis of the iliac arteries. In this case the bypass graft was used for introduction of the stent-graft.
RESULTS:
A total of 46 stent-grafts were implanted: Vanguard/Stentor (n = 4), Talent (n = 31), and Valiant (n = 11). Stent-graft extension was necessary in 7 cases. In 3 cases primary graft extension was done during the initial procedure (in 1 case due to distal migration of the graft during stent release, in 2 cases due to the total length of the aortic aneurysm). In 4 cases secondary graft extensions were performed--for new aortic ulcers at the proximal stent struts (after 5 days) and distal to the graft (after 8 months) and recurrent aortobronchial fistulas 5 months and 9 years after the initial procedure--resulting in a total of 41 endovascular procedures. The 30-day mortality rate was 8% (3 of 37) and the overall follow-up was 29.9 +/- 36.6 months (range 0-139 months). All patients with traumatic ruptures demonstrated an immediate sealing of bleeding. Patients with aortobronchial fistulas also demonstrated a satisfactory follow-up despite the necessity for reintervention and graft extension in 3 of 6 cases (50%). Two patients with type B dissection died due to mesenteric ischemia despite sufficient mesenteric blood flow being restored (but too late). Two suffered from neurologic complications, 1 from paraplegia and 1 from cerebral ischemia (probably embolic), 1 from penetrating ulcer, and 1 from persistent ischemia of the kidney. Five of 9 (56%) patients with symptomatic thoracic aneurysm demonstrated endoleaks during follow-up and there was an increase in the aneurysm in 1.
CONCLUSION:
Endovascular treatment is safe and effective for emergency treatment of life-threatening acute thoracic aortic syndromes. Results are encouraging, particularly for traumatic aortic ruptures. However, regular follow-up is mandatory, particularly in the other pathologies, to identify late complications of the stent-graft and to perform appropriate additional corrections as required.
AuthorsM B Pitton, S Herber, W Schmiedt, A Neufang, B Dorweiler, C Düber
JournalCardiovascular and interventional radiology (Cardiovasc Intervent Radiol) 2008 Jan-Feb Vol. 31 Issue 1 Pg. 23-35 ISSN: 1432-086X [Electronic] United States
PMID17943352 (Publication Type: Journal Article)
Topics
  • Acute Disease
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Aorta (injuries, surgery)
  • Aortic Aneurysm, Thoracic (complications, diagnosis, surgery)
  • Aortic Diseases (diagnosis, etiology, surgery)
  • Aortic Rupture (complications, diagnosis, surgery)
  • Aortography (methods)
  • Emergency Treatment (methods)
  • Female
  • Fistula (complications, diagnosis, surgery)
  • Follow-Up Studies
  • Hematoma (complications, diagnosis, surgery)
  • Humans
  • Ischemia (complications, diagnosis, surgery)
  • Male
  • Middle Aged
  • Postoperative Complications (diagnosis)
  • Rupture (diagnosis, therapy)
  • Stents (adverse effects)
  • Survival Analysis
  • Time
  • Tomography, X-Ray Computed (methods)
  • Treatment Outcome
  • Ulcer (complications, diagnosis, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: